Gujarat Kidney and Super Speciality Ltd

Gujarat Kidney and Super Speciality Ltd

Gujarat Kidney and Super Speciality Ltd has announced the dispatch of the annual report for 2025-26, including the Notice of 7th Annual General Meeting and procedure for e-voting. The company has also announced the newspaper publication of the same.

Gujarat Kidney and Super Speciality Ltd

Gujarat Kidney and Super Speciality Ltd has announced that its Annual General Meeting (AGM) will be held on 28-09-2026.

Gujarat Kidney and Super Speciality Ltd

Gujarat Kidney and Super Speciality Ltd has filed its revised annual report.

Gujarat Kidney and Super Speciality Ltd

Gujarat Kidney and Super Speciality Ltd has announced its Annual Report for the financial year 2025-26, along with the notice for the 7th Annual General Meeting to be held on September 28, 2026. The meeting will consider the adoption of audited financial statements, appointment of a director, and other business.

Gujarat Kidney and Super Speciality Ltd

Gujarat Kidney and Super Speciality Ltd has announced the pre-advertisement notice of its 7th Annual General Meeting (AGM) to be held on September 28, 2026. The meeting will be held in physical mode, and the information will also be available on the company's website.

Gujarat Kidney and Super Speciality Ltd

Gujarat Kidney and Super Speciality Ltd has announced an investor meet on August 31, 2026, as part of GIA Healthcare Day, where the company's management will discuss publicly available documents and no unpublished price-sensitive information will be shared.

Gujarat Kidney and Super Speciality Ltd

Gujarat Kidney and Super Speciality Ltd has appointed Mrs. Disha Bharpoda as an Additional Non-Executive Independent Director, not liable to retire by rotation, for a first term of five consecutive years, subject to the approval by the Members of the Company.

Gujarat Kidney and Super Speciality Ltd

Gujarat Kidney and Super Speciality Ltd has appointed Mrs. Disha Bharpoda as an Additional Non-Executive Independent Director, subject to shareholder approval at the next Annual General Meeting.

Gujarat Kidney and Super Speciality Ltd

Gujarat Kidney and Super Speciality Ltd has appointed Mrs. Disha Bharpoda as an Additional Non-Executive Independent Director, subject to shareholder approval at the next Annual General Meeting.

Gujarat Kidney and Super Speciality Ltd

Gujarat Kidney and Super Speciality Ltd announced the outcome of its postal ballot, but the content is unclear due to the presence of unclear characters and formatting.

Gujarat Kidney and Super Speciality Ltd

Gujarat Kidney and Super Speciality Ltd has declared the result of its shareholder meeting/postal ballot.

Gujarat Kidney and Super Speciality Ltd

Gujarat Kidney and Super Speciality Ltd has received the Third Monitoring Agency Report for the quarter ended June 30, 2026, from Brickwork Ratings, which states that the funds raised by the company through a fresh issue of equity shares aggregating to Rs. 250.80 Crore have been utilized as per the objects of the issue.

Gujarat Kidney and Super Speciality Ltd

Gujarat Kidney and Super Speciality Ltd has filed a statement of deviation and variation for the first quarter and three months period ended on June 30, 2026, stating that there was no deviation in the utilization of proceeds of IPO from the objects stated in the offer document.

Gujarat Kidney and Super Speciality Ltd

Gujarat Kidney and Super Speciality Ltd has announced its unaudited financial results for the quarter ended June 2026, with the independent auditor's review report stating that nothing has come to their attention that causes them to believe the financial results contain any material misstatement.

Gujarat Kidney and Super Speciality Ltd

Gujarat Kidney and Super Speciality Ltd has announced the change in category of Mr Paresh Dhoti from Additional Director - Non Executive- Non Independent to Additional Director- Non Executive-Independent. The appointment is subject to approval by the Members of the Company at the ensuing Annual General Meeting.

Gujarat Kidney and Super Speciality Ltd

Gujarat Kidney and Super Speciality Ltd's unaudited financial results for the quarter ended June 30, 2026, have been reviewed by independent auditors Y. M. Shah & Co. The review report states that nothing has come to their attention that causes them to believe the financial results contain material misstatements. The company's management is responsible for the preparation of the financial results in accordance with Indian Accounting Standards.

Gujarat Kidney and Super Speciality Ltd

Gujarat Kidney and Super Speciality Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 14/08/2026 to consider and approve Unaudited standalone and consolidated financial results for the Quarter ended on June 30, 2026.

Gujarat Kidney and Super Speciality Ltd

Gujarat Kidney and Super Speciality Ltd has published a notice of postal ballot in newspapers as per Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Gujarat Kidney and Super Speciality Ltd

Gujarat Kidney and Super Speciality Ltd clarifies the appointment of Mr. Paresh Dhoti as a Non-Executive Non-Independent Director due to technical glitches in the registration process.